Search

Conantokins: Peptide Antagonists of NMDA Receptors

Journal: Current Medicinal Chemistry
Volume: 11 Issue: 2 Year: 2004 Page: 3073-3084
Author(s): Richard T. Layer, John D. Wagstaff, H. Steve White

TCR Peptide Vaccination in Multiple Sclerosis: Boosting a Deficient Natural Regulatory Network that may Involve TCR-Specific CD4+CD25+ Treg Cells

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4 Issue: 2 Year: 2005 Page: 217-229
Author(s): Arthur A. Vandenbark

Journal: Current Alzheimer Research
Volume: 11 Issue: 1 Year: 2014 Page: 79-85
Author(s): C. Kairane, R. Mahlapuu, K. Ehrlich, M. Zilmer, U. Soomets

Nonsense-Mediated mRNA Decay: A Comparative Analysis of Different Species

Journal: Current Genomics
Volume: 5 Issue: 3 Year: 2004 Page: 175-190
Author(s): L. E. Maquat

Chemoprevention of Lung Pathologies by Dietary n-3 Polyunsaturated Fatty Acids

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 3358-3376
Author(s): E. Fasano, S. Serini, E. Piccioni, G. Calviello

Cytotoxic Phytochemicals from Mushrooms as Potential Therapeutic Agents

Ebook: Alternative Remedies and Natural Products for Cancer Therapy: An Integrative Approach
Volume: 1 Year: 2023
Author(s):
Doi: 10.2174/9789815124699123010012

Multiscale Molecular Dynamics of Protein Aggregation

Journal: Current Protein & Peptide Science
Volume: 12 Issue: 3 Year: 2011 Page: 221-234
Author(s): Cesar L. Avila, Nils J. D. Drechsel, Raul Alcantara, Jordi Villa-Freixa

Development of Recombinant Therapeutic Proteins in Animal Cells: Challenges and Solutions

Ebook: Frontiers in Drug Design and Discovery
Volume: 11 Year: 2022
Author(s): Eduardo F. Mufarrege,Lucía Carolina Peña
Doi: 10.2174/9789815036879122110004

Insights from Mouse Models to Understand Neurodegeneration in Down Syndrome

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2010 Page: 429-438
Author(s): Cristina Fillat, Mara Dierssen, Maria Martinez de Lagran, Xavier Altafaj

Targeting Kynurenine 3-Monooxygenase (KMO): Implications for Therapy in Huntingtons Disease

Journal: CNS & Neurological Disorders - Drug Targets
Volume: 9 Issue: 6 Year: 2010 Page: 791-800
Author(s): Mathuravani A. Thevandavakkam, Robert Schwarcz, Paul J. Muchowski, Flaviano Giorgini